PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
180.25K
Worse than TGTX's estimated revenue of 231.08M.
-36.05K
Better than TGTX's estimated ebitda of -179.70M.
-2.06
Worse than TGTX's estimated eps of -0.01.
-62.22M
Worse than TGTX's estimated net income of -1.70M.
-36.05K
Better than TGTX's estimated ebit of -179.78M.
6.68M
Better than TGTX's estimated sg&a expense of 45.83B.
Analyze DCF forecasts for the company and compare them with competitors.
No Data
No DCF data available for this metric in the selected year.
-50.53%
Worse than TGTX's revenue growth rate of 45.61%.
No Data
No DCF data available for this metric in the selected year.
-20.00%
Better than TGTX's ebitda margin of -54.73%.
No Data
No DCF data available for this metric in the selected year.
-20.00%
Better than TGTX's ebit margin of -54.79%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
100.00%
Better than TGTX's cash as percentage of revenue of 97.52%.
No Data
No DCF data available for this metric in the selected year.
40.00%
Worse than TGTX's receivables as percentage of revenue of 16.38%.
No Data
No DCF data available for this metric in the selected year.
40.00%
Worse than TGTX's inventories as percentage of revenue of -9.88%.
No Data
No DCF data available for this metric in the selected year.
100.00%
Worse than TGTX's payables as percentage of revenue of 43.29%.
No Data
No DCF data available for this metric in the selected year.
-29.43%
Better than TGTX's capex as percentage of revenue of -21.30%.
4.99%
Better than TGTX's weighted average cost of capital (wacc) of 14.26%.
5.02%
Better than TGTX's cost of equity of 14.49%.
4.08%
Better than TGTX's cost of debt of 9.47%.
-0.23
Better than TGTX's beta of 2.21.
30.07M
Better than TGTX's diluted shares outstanding of 160.34M.
1.57M
Better than TGTX's total debt of 253.72M.
49.31M
Worse than TGTX's total equity of 5.61B.
50.89M
Worse than TGTX's total capital of 5.86B.
3.09%
Better than TGTX's debt weighting of 4.33%.
96.91%
Better than TGTX's equity weighting of 95.67%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
2.00%
Equal to TGTX's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Better than TGTX's net debt of 73.83M.
71.33M
Better than TGTX's equity value of -4.63B.
2.37
Better than TGTX's equity value per share of -28.90.